\-\ Texto\\:\\ \ \(0\)\
\-\ on\\ initial\\ evaluation\\,\\ the\\ patient\\ was\\ pleasant\\ and\\ cooperative\\ with\\ all\\ vitals\\ within\\ normal\\ limits\\.\\ \\ the\\ external\\ ear\\ canal\\ was\\ patent\\.\\ \\ the\\ tympanic\\ membrane\\ was\\ non\\-injected\\ and\\ appropriately\\ mobile\\ without\\ scarring\\ or\\ fluid\\ within\\ the\\ middle\\-ear\\.\\ \\ initial\\ speech\\ language\\ pathology\\ assessment\\ showed\\ significant\\ receptive\\,\\ expressive\\ and\\ articulation\\ deficits\\ resulting\\ in\\ reduced\\ pragmatic\\/play\\ skills\\.\\ \\ audiological\\ assessment\\ showed\\ a\\ speech\\ awareness\\ threshold\\ of\\ 40\\ bilaterally\\ at\\ the\\ middle\\ level\\ of\\ hearing\\.\\ \\ tympanometry\\ results\\ were\\ normal\\ bilaterally\\.\\ \\ responses\\ to\\ tonal\\ stimuli\\ in\\ the\\ right\\ ear\\ were\\ moderately\\-severe\\,\\ sloping\\ to\\ a\\ severe\\ level\\ of\\ hearing\\ at\\ 1\\ khz\\ and\\ 4\\ khz\\.\\ \\ responses\\ to\\ tonal\\ stimuli\\ were\\ unremarkable\\ in\\ the\\ left\\ ear\\.\\ \\ unmasked\\ bone\\ conduction\\ responses\\ were\\ consistent\\ with\\ a\\ sensorineural\\ component\\.\\ \\ distortion\\ product\\ otoacoustic\\ emissions\\ were\\ present\\ at\\ 2\\ khz\\ in\\ the\\ right\\ ear\\ and\\ emissions\\ were\\ absent\\ at\\ 3\\-6\\ khz\\ in\\ right\\ ear\\.\ \(0\)\
\-\ patient\\ was\\ fitted\\ with\\ a\\ phonak\\ aero\\ behind\\ the\\ ear\\ 311\\ hearing\\ aids\\ at\\ a\\ volume\\ setting\\ of\\ 2\\?\\ \\ which\\ resulted\\ in\\ assisted\\ speech\\ reception\\ thresholds\\ at\\ a\\ normal\\ to\\ borderline\\-normal\\ \\(20\\-25\\ db\\)\\ level\\ of\\ hearing\\ in\\ soundfield\\.\\ \\ the\\ hearing\\ aids\\ required\\ a\\ subsequent\\ volume\\ adjustment\\ to\\ 2\\ bilaterally\\ at\\ audiological\\ follow\\-up\\.\\ \\ the\\ patient\\ was\\ referred\\ to\\ speech\\ and\\ aural\\ rehabilitation\\ therapy\\.\\ \\ \ \(0\)\
\-\ the\\ patient\\ was\\ seen\\ for\\ follow\\-up\\ over\\ five\\ years\\.\\ \\ she\\ continued\\ to\\ show\\ a\\ stable\\ response\\ to\\ aided\\ hearing\\ with\\ hearing\\ aides\\ that\\ were\\ finely\\ adjusted\\ during\\ regular\\ audiological\\ assessment\\ and\\ testing\\.\\ \\ over\\ the\\ five\\ years\\ of\\ follow\\-up\\,\\ the\\ patient\\â\\€\\™s\\ hearing\\ loss\\ was\\ non\\-progressive\\.\\ \\ his\\ thyroid\\ and\\ renal\\ function\\ remained\\ normal\\ during\\ follow\\-up\\.\ \(0\)\
\-\ a\\ ct\\ scan\\ of\\ the\\ internal\\ auditory\\ canal\\ and\\ temporal\\ bones\\ was\\ obtained\\ which\\ showed\\ the\\ external\\ auditory\\ canals\\ to\\ be\\ widely\\ patent\\ bilaterally\\ with\\ a\\ well\\-aerated\\ middle\\ ear\\.\\ \\ there\\ was\\ no\\ abnormal\\ soft\\ tissue\\ or\\ fluid\\ density\\ identified\\ within\\ the\\ middle\\ ear\\.\\ \\ the\\ ossicles\\ had\\ a\\ normal\\ appearance\\.\\ \\ the\\ aditus\\ ad\\ antrum\\ and\\ mastoid\\ air\\ cells\\ were\\ well\\ aerated\\ bilaterally\\.\\ \\ the\\ cochlea\\ and\\ semicircular\\ canals\\ were\\ fully\\ formed\\.\\ \\ the\\ internal\\ auditory\\ canals\\ had\\ a\\ symmetric\\ appearance\\.\\ \\ the\\ vestibular\\ aqueduct\\ was\\ abnormally\\ enlarged\\ on\\ the\\ right\\ but\\ was\\ normal\\ on\\ the\\ left\\.\ \(0\)\
\-\ enlarged\\ vestibular\\ aqueduct\\ syndrome\ \(1\)\
\-\ \\â\\€\\¢\\ \\ nonsyndromic\\ hearing\\ loss\\ and\\ deafness\ \(0\)\
\-\ \\â\\€\\¢\\ \\ iatrogenic\\ ototoxicity\\ \ \(0\)\
\-\ \\â\\€\\¢\\ \\ intrauterine\\ infections\ \(0\)\
\-\ \\â\\€\\¢\\ \\ down\\â\\€\\™s\\ syndrome\ \(0\)\
\-\ \\â\\€\\¢\\ \\ waardenburg\\'s\\ syndromes\ \(0\)\
\-\ \\â\\€\\¢\\ \\ otosclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ \\ non\\-patent\\ external\\ auditory\\ canal\ \(0\)\
\-\ \\â\\€\\¢\\ \\ meningitis\ \(0\)\
\-\ \\â\\€\\¢\\ \\ menieres\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ \\ head\\ trauma\ \(0\)\
\-\ \\â\\€\\¢\\ \\ untreated\\ middle\\ ear\\ infections\ \(0\)\
\-\ \\â\\€\\¢\\ \\ pendred\\ syndrome\ \(0\)\
\-\ the\\ patient\\ is\\ a\\ 3\\ year\\ old\\ girl\\ who\\ was\\ referred\\ to\\ a\\ speech\\ language\\ pathologist\\ and\\ audiologist\\ for\\ evaluation\\ of\\ delayed\\ speech\\ and\\ poor\\ hearing\\.\\ \ \(0\)\
\-\ pmh\\:\\ \\ c\\-section\\ at\\ 35\\ weeks\\ for\\ for\\ low\\ amniotic\\ fluid\\ and\\ a\\ non\\-reassuring\\ fetal\\ heart\\ rate\\.\\ \\ she\\ failed\\ her\\ newborn\\ hearing\\ screening\\ but\\ received\\ no\\ follow\\-up\\ assessment\\ until\\ she\\ was\\ 3\\ years\\ old\\ and\\ presented\\ with\\ concerns\\ for\\ delayed\\ attainment\\ of\\ speech\\,\\ language\\ and\\ motor\\ milestones\\.\\ \\ at\\ this\\ time\\ of\\ presentation\\,\\ she\\ was\\ using\\ only\\ single\\ words\\ in\\ small\\ sentences\\ to\\ communicate\\.\\ \\ the\\ parents\\ denied\\ a\\ history\\ otitis\\ media\\,\\ head\\ trauma\\ or\\ hearing\\ loss\\ in\\ the\\ family\\.\ \(0\)\
\-\ the\\ patient\\ was\\ diagnosed\\ with\\ enlarged\\ vestibular\\ aqueduct\\ syndrome\\.\\ \\ initial\\ imaging\\ showed\\ an\\ enlarged\\ vestibular\\ aqueduct\\ which\\ is\\ commonly\\ associated\\ with\\ multiple\\ syndromes\\,\\ most\\ commonly\\ pendred\\ and\\ nonsyndromic\\ hearing\\ loss\\ and\\ deafness\\ which\\ were\\ both\\ ruled\\ out\\ by\\ genetic\\ mutation\\ analysis\\.\\ \\ she\\ was\\ treated\\ with\\ hearing\\ aids\\ resulting\\ in\\ a\\ significant\\ improvement\\ in\\ speech\\ recognition\\.\\ \\ she\\ was\\ advised\\ to\\ avoid\\ all\\ contact\\ sports\\ to\\ prevent\\ a\\ sudden\\ traumatic\\ hearing\\ deficit\\.\\ \\ her\\ hearing\\ remained\\ stable\\ over\\ the\\ course\\ of\\ a\\ five\\ year\\ follow\\-up\\ period\\.\\ \\ she\\ will\\ be\\ followed\\ with\\ yearly\\ visits\\ for\\ audiological\\ testing\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hearing\\:\\ 0\\.10525870594946017\ \(0\)\
\-\ speech\\:\\ 0\\.061546226573198394\ \(0\)\
\-\ ear\\:\\ 0\\.05920802209657134\ \(0\)\
\-\ khz\\:\\ 0\\.055096990149790616\ \(0\)\
\-\ audiological\\:\\ 0\\.05076482027129096\ \(0\)\
\-\ aqueduct\\:\\ 0\\.03738940674943927\ \(0\)\
\-\ language\\:\\ 0\\.03292387010033645\ \(0\)\
\-\ vestibular\\:\\ 0\\.0306468463658647\ \(0\)\
\-\ auditory\\:\\ 0\\.03040171690865669\ \(0\)\
\-\ were\\:\\ 0\\.03031697401078002\ \(0\)\
\-\ responses\\:\\ 0\\.029674742691461704\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.029381519092422897\ \(0\)\
\-\ assessment\\:\\ 0\\.028725066992439947\ \(0\)\
\-\ tonal\\:\\ 0\\.027548495074895308\ \(0\)\
\-\ canals\\:\\ 0\\.026625113475175072\ \(0\)\
\-\ was\\:\\ 0\\.026251121683801056\ \(0\)\
\-\ she\\:\\ 0\\.02623672342215501\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.02606284679476633\ \(0\)\
\-\ emissions\\:\\ 0\\.02538241013564548\ \(0\)\
\-\ nonsyndromic\\:\\ 0\\.02538241013564548\ \(0\)\
\-\ pendred\\:\\ 0\\.02538241013564548\ \(0\)\
\-\ aids\\:\\ 0\\.02507710556796924\ \(0\)\
\-\ stimuli\\:\\ 0\\.022519001598538743\ \(0\)\
\-\ deafness\\:\\ 0\\.022519001598538743\ \(0\)\
\-\ bilaterally\\:\\ 0\\.021927384675967995\ \(0\)\
\-\ five\\:\\ 0\\.019976444682965427\ \(0\)\
\-\ middle\\:\\ 0\\.019532243560265238\ \(0\)\
\-\ enlarged\\:\\ 0\\.01822263168990004\ \(0\)\
\-\ showed\\:\\ 0\\.017511270424523103\ \(0\)\
\-\ external\\:\\ 0\\.01703313222034881\ \(0\)\
\-\ at\\:\\ 0\\.01628104433669484\ \(0\)\
\-\ canal\\:\\ 0\\.01591398480325412\ \(0\)\
\-\ loss\\:\\ 0\\.015502901077927747\ \(0\)\
\-\ syndrome\\:\\ 0\\.01527441610459151\ \(0\)\
\-\ syndromes\\:\\ 0\\.015261539972631789\ \(0\)\
\-\ remained\\:\\ 0\\.014551985439396332\ \(0\)\
\-\ non\\-injected\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ middle\\-ear\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ pragmatic\\/play\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ tympanometry\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ moderately\\-severe\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ unmasked\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ otoacoustic\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ phonak\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ aero\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ 311\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ borderline\\-normal\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ soundfield\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ finely\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ non\\-progressive\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ well\\-aerated\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ aditus\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ ototoxicity\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ waardenburg\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ non\\-patent\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ menieres\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ audiologist\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ attainment\\:\\ 0\\.013774247537447654\ \(0\)\
\-\ initial\\:\\ 0\\.013273041296621756\ \(0\)\
\-\ patent\\:\\ 0\\.013157338243682521\ \(0\)\
\-\ testing\\:\\ 0\\.01291683499013212\ \(0\)\
\-\ infections\\:\\ 0\\.01269352572768792\ \(0\)\
\-\ receptive\\:\\ 0\\.01269120506782274\ \(0\)\
\-\ reception\\:\\ 0\\.01269120506782274\ \(0\)\
\-\ thresholds\\:\\ 0\\.01269120506782274\ \(0\)\
\-\ aural\\:\\ 0\\.01269120506782274\ \(0\)\
\-\ aides\\:\\ 0\\.01269120506782274\ \(0\)\
\-\ non\\-reassuring\\:\\ 0\\.01269120506782274\ \(0\)\
\-\ sentences\\:\\ 0\\.01269120506782274\ \(0\)\
\-\ volume\\:\\ 0\\.012613734158921778\ \(0\)\
\-\ normal\\:\\ 0\\.012558866761866572\ \(0\)\
\-\ aided\\:\\ 0\\.012057665836403733\ \(0\)\
\-\ otosclerosis\\:\\ 0\\.012057665836403733\ \(0\)\
\-\ a\\:\\ 0\\.011774056616489725\ \(0\)\
\-\ years\\:\\ 0\\.011762077204774136\ \(0\)\
\-\ resulting\\:\\ 0\\.011727885596686036\ \(0\)\
\-\ sloping\\:\\ 0\\.011608162598197825\ \(0\)\
\-\ fitted\\:\\ 0\\.011608162598197825\ \(0\)\
\-\ db\\:\\ 0\\.011608162598197825\ \(0\)\
\-\ adjustment\\:\\ 0\\.011608162598197825\ \(0\)\
\-\ adjusted\\:\\ 0\\.011608162598197825\ \(0\)\
\-\ level\\:\\ 0\\.011544792317094993\ \(0\)\
\-\ fluid\\:\\ 0\\.011384245802830562\ \(0\)\
\-\ pathologist\\:\\ 0\\.011259500799269372\ \(0\)\
\-\ stable\\:\\ 0\\.01100691749763127\ \(0\)\
\-\ delayed\\:\\ 0\\.010868688575828688\ \(0\)\
\-\ ossicles\\:\\ 0\\.01052512012857291\ \(0\)\
\-\ expressive\\:\\ 0\\.01034108413535981\ \(0\)\
\-\ threshold\\:\\ 0\\.01034108413535981\ \(0\)\
\-\ semicircular\\:\\ 0\\.01034108413535981\ \(0\)\
\-\ over\\:\\ 0\\.010198324641281073\ \(0\)\
\-\ cooperative\\:\\ 0\\.010176458329644457\ \(0\)\
\-\ 20\\-25\\:\\ 0\\.010176458329644457\ \(0\)\
\-\ cochlea\\:\\ 0\\.010176458329644457\ \(0\)\
\-\ words\\:\\ 0\\.010176458329644457\ \(0\)\
\-\ referred\\:\\ 0\\.01007666076079888\ \(0\)\
\-\ commonly\\:\\ 0\\.01007666076079888\ \(0\)\
\-\ pleasant\\:\\ 0\\.0100275361737002\ \(0\)\
\-\ skills\\:\\ 0\\.0100275361737002\ \(0\)\
\-\ milestones\\:\\ 0\\.0100275361737002\ \(0\)\
\-\ which\\:\\ 0\\.00996965367026593\ \(0\)\
\-\ articulation\\:\\ 0\\.009766514166414003\ \(0\)\
\-\ awareness\\:\\ 0\\.009766514166414003\ \(0\)\
\-\ aerated\\:\\ 0\\.009766514166414003\ \(0\)\
\-\ concerns\\:\\ 0\\.009766514166414003\ \(0\)\
\-\ visits\\:\\ 0\\.00954291909822545\ \(0\)\
\-\ recognition\\:\\ 0\\.009442077658947995\ \(0\)\
\-\ patient\\:\\ 0\\.009368974244397994\ \(0\)\
\-\ sensorineural\\:\\ 0\\.009347351687359817\ \(0\)\
\-\ communicate\\:\\ 0\\.009347351687359817\ \(0\)\
\-\ product\\:\\ 0\\.009258041665734898\ \(0\)\
\-\ 3\\-6\\:\\ 0\\.009258041665734898\ \(0\)\
\-\ amniotic\\:\\ 0\\.009258041665734898\ \(0\)\
\-\ ad\\:\\ 0\\.009093415860019542\ \(0\)\
\-\ yearly\\:\\ 0\\.009017181228504804\ \(0\)\
\-\ internal\\:\\ 0\\.00895273709805866\ \(0\)\
\-\ rehabilitation\\:\\ 0\\.008808538427528987\ \(0\)\
\-\ widely\\:\\ 0\\.008808538427528987\ \(0\)\
\-\ untreated\\:\\ 0\\.008808538427528987\ \(0\)\
\-\ otitis\\:\\ 0\\.00874475406109109\ \(0\)\
\-\ to\\:\\ 0\\.008674820952748158\ \(0\)\
\-\ 2\\:\\ 0\\.008625489827393185\ \(0\)\
\-\ tympanic\\:\\ 0\\.00862450243431589\ \(0\)\
\-\ assisted\\:\\ 0\\.00862450243431589\ \(0\)\
\-\ conduction\\:\\ 0\\.008567677990298898\ \(0\)\
\-\ c\\-section\\:\\ 0\\.008512847803093788\ \(0\)\
\-\ media\\:\\ 0\\.008512847803093788\ \(0\)\
\-\ mutation\\:\\ 0\\.008512847803093788\ \(0\)\
\-\ antrum\\:\\ 0\\.008459876628600536\ \(0\)\
\-\ intrauterine\\:\\ 0\\.008459876628600536\ \(0\)\
\-\ advised\\:\\ 0\\.008408642530439613\ \(0\)\
\-\ appropriately\\:\\ 0\\.008310954472656278\ \(0\)\
\-\ formed\\:\\ 0\\.008264309217734902\ \(0\)\
\-\ contact\\:\\ 0\\.008264309217734902\ \(0\)\
\-\ sports\\:\\ 0\\.008264309217734902\ \(0\)\
\-\ during\\:\\ 0\\.0081719039060119\ \(0\)\
\-\ iatrogenic\\:\\ 0\\.008132188298941053\ \(0\)\
\-\ fully\\:\\ 0\\.008090519162875176\ \(0\)\
\-\ her\\:\\ 0\\.008029411432765424\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.00798133356139205\ \(0\)\
\-\ distortion\\:\\ 0\\.00793413875887989\ \(0\)\
\-\ membrane\\:\\ 0\\.00782633739718153\ \(0\)\
\-\ scarring\\:\\ 0\\.007791995355433443\ \(0\)\
\-\ parents\\:\\ 0\\.007758391909775688\ \(0\)\
\-\ evaluation\\:\\ 0\\.007756996236958774\ \(0\)\
\-\ avoid\\:\\ 0\\.007725495957904074\ \(0\)\
\-\ mastoid\\:\\ 0\\.007693278321649799\ \(0\)\
\-\ s\\:\\ 0\\.007658648959733085\ \(0\)\
\-\ within\\:\\ 0\\.007641240976809757\ \(0\)\
\-\ appearance\\:\\ 0\\.007637208052295755\ \(0\)\
\-\ mobile\\:\\ 0\\.007600429227164173\ \(0\)\
\-\ head\\:\\ 0\\.007573754095543426\ \(0\)\
\-\ all\\:\\ 0\\.007552885904472784\ \(0\)\
\-\ resulted\\:\\ 0\\.007541459964690975\ \(0\)\
\-\ failed\\:\\ 0\\.007456979931456169\ \(0\)\
\-\ ruled\\:\\ 0\\.007429805333468874\ \(0\)\
\-\ abnormally\\:\\ 0\\.007351007124676855\ \(0\)\
\-\ trauma\\:\\ 0\\.007303152442993528\ \(0\)\
\-\ genetic\\:\\ 0\\.0073005995274608845\ \(0\)\
\-\ newborn\\:\\ 0\\.007275992719698166\ \(0\)\
\-\ in\\:\\ 0\\.007242764893035632\ \(0\)\
\-\ significant\\:\\ 0\\.007180772347044448\ \(0\)\
\-\ behind\\:\\ 0\\.007049145829316138\ \(0\)\
\-\ reduced\\:\\ 0\\.007028172360047169\ \(0\)\
\-\ meningitis\\:\\ 0\\.006927330920769713\ \(0\)\
\-\ deficit\\:\\ 0\\.006888748713597258\ \(0\)\
\-\ for\\:\\ 0\\.006835388893525454\ \(0\)\
\-\ fetal\\:\\ 0\\.006796266102049867\ \(0\)\
\-\ analysis\\:\\ 0\\.006796266102049867\ \(0\)\
\-\ setting\\:\\ 0\\.006743294927556615\ \(0\)\
\-\ response\\:\\ 0\\.006692060829395691\ \(0\)\
\-\ pmh\\:\\ 0\\.00664245348827916\ \(0\)\
\-\ prevent\\:\\ 0\\.006626261633536118\ \(0\)\
\-\ denied\\:\\ 0\\.006502434490326524\ \(0\)\
\-\ vitals\\:\\ 0\\.0063877040707096214\ \(0\)\
\-\ the\\:\\ 0\\.006264420713133044\ \(0\)\
\-\ 3\\:\\ 0\\.006253048520957937\ \(0\)\
\-\ period\\:\\ 0\\.006242557591189784\ \(0\)\
\-\ improvement\\:\\ 0\\.0062300073229128086\ \(0\)\
\-\ received\\:\\ 0\\.006205205214856105\ \(0\)\
\-\ sudden\\:\\ 0\\.006168724958610806\ \(0\)\
\-\ regular\\:\\ 0\\.006156751719945855\ \(0\)\
\-\ 35\\:\\ 0\\.006144869533406449\ \(0\)\
\-\ deficits\\:\\ 0\\.006109755696137607\ \(0\)\
\-\ component\\:\\ 0\\.006098224278485073\ \(0\)\
\-\ symmetric\\:\\ 0\\.006098224278485073\ \(0\)\
\-\ poor\\:\\ 0\\.006008914256860153\ \(0\)\
\-\ until\\:\\ 0\\.005863942798343018\ \(0\)\
\-\ using\\:\\ 0\\.005796207734477997\ \(0\)\
\-\ absent\\:\\ 0\\.005786766618140555\ \(0\)\
\-\ had\\:\\ 0\\.005762030685127213\ \(0\)\
\-\ continued\\:\\ 0\\.00574956247955662\ \(0\)\
\-\ down\\:\\ 0\\.005731287417426633\ \(0\)\
\-\ screening\\:\\ 0\\.005695366295200541\ \(0\)\
\-\ but\\:\\ 0\\.005695322815729806\ \(0\)\
\-\ function\\:\\ 0\\.0056602524579317005\ \(0\)\
\-\ right\\:\\ 0\\.005635198181940105\ \(0\)\
\-\ bones\\:\\ 0\\.005634425423632934\ \(0\)\
\-\ 40\\:\\ 0\\.005617441560762771\ \(0\)\
\-\ traumatic\\:\\ 0\\.0055923069705258585\ \(0\)\
\-\ motor\\:\\ 0\\.0055757724246968945\ \(0\)\
\-\ limits\\:\\ 0\\.005503458748815635\ \(0\)\
\-\ thyroid\\:\\ 0\\.005472363195194861\ \(0\)\
\-\ family\\:\\ 0\\.005472363195194861\ \(0\)\
\-\ pathology\\:\\ 0\\.005464685047066066\ \(0\)\
\-\ single\\:\\ 0\\.0054119692038913\ \(0\)\
\-\ results\\:\\ 0\\.005389910013976011\ \(0\)\
\-\ cells\\:\\ 0\\.005353822959609371\ \(0\)\
\-\ temporal\\:\\ 0\\.005346704496272089\ \(0\)\
\-\ and\\:\\ 0\\.005344017357675235\ \(0\)\
\-\ \\?\\:\\ 0\\.005210749219725792\ \(0\)\
\-\ rate\\:\\ 0\\.005204252328868505\ \(0\)\
\-\ subsequent\\:\\ 0\\.005197782340327831\ \(0\)\
\-\ course\\:\\ 0\\.00503833038039944\ \(0\)\
\-\ diagnosed\\:\\ 0\\.004909679932492196\ \(0\)\
\-\ required\\:\\ 0\\.0048058211121676\ \(0\)\
\-\ identified\\:\\ 0\\.004771042251853628\ \(0\)\
\-\ obtained\\:\\ 0\\.004746665782412254\ \(0\)\
\-\ or\\:\\ 0\\.0046946378857673785\ \(0\)\
\-\ girl\\:\\ 0\\.004694339735921559\ \(0\)\
\-\ heart\\:\\ 0\\.004639186951419959\ \(0\)\
\-\ presentation\\:\\ 0\\.004599063491392316\ \(0\)\
\-\ air\\:\\ 0\\.0045175978539874475\ \(0\)\
\-\ followed\\:\\ 0\\.00447636854902933\ \(0\)\
\-\ unremarkable\\:\\ 0\\.00442041627919072\ \(0\)\
\-\ out\\:\\ 0\\.004412584182591431\ \(0\)\
\-\ density\\:\\ 0\\.0043931739950936865\ \(0\)\
\-\ will\\:\\ 0\\.004177314091217409\ \(0\)\
\-\ be\\:\\ 0\\.0041179897604497785\ \(0\)\
\-\ severe\\:\\ 0\\.004108296562603132\ \(0\)\
\-\ show\\:\\ 0\\.004098681147643166\ \(0\)\
\-\ only\\:\\ 0\\.004014705716382712\ \(0\)\
\-\ renal\\:\\ 0\\.004011680546028233\ \(0\)\
\-\ treated\\:\\ 0\\.00399664193138103\ \(0\)\
\-\ his\\:\\ 0\\.0038482641056983313\ \(0\)\
\-\ abnormal\\:\\ 0\\.003807956625492049\ \(0\)\
\-\ weeks\\:\\ 0\\.0037894964951580446\ \(0\)\
\-\ time\\:\\ 0\\.003771251917561426\ \(0\)\
\-\ scan\\:\\ 0\\.003737924156926529\ \(0\)\
\-\ 4\\:\\ 0\\.0037202686018422584\ \(0\)\
\-\ low\\:\\ 0\\.0037127625826037496\ \(0\)\
\-\ presented\\:\\ 0\\.0036396213047225146\ \(0\)\
\-\ therapy\\:\\ 0\\.003569751244125958\ \(0\)\
\-\ who\\:\\ 0\\.0034812006392839095\ \(0\)\
\-\ both\\:\\ 0\\.0034096874854470647\ \(0\)\
\-\ on\\:\\ 0\\.003393239120462944\ \(0\)\
\-\ \\,\\:\\ 0\\.0033838758189660926\ \(0\)\
\-\ bone\\:\\ 0\\.003317866689781047\ \(0\)\
\-\ consistent\\:\\ 0\\.003273903545048755\ \(0\)\
\-\ soft\\:\\ 0\\.0032514480687399223\ \(0\)\
\-\ 1\\:\\ 0\\.003177072449937042\ \(0\)\
\-\ tissue\\:\\ 0\\.003164720606957178\ \(0\)\
\-\ associated\\:\\ 0\\.0031507227529807844\ \(0\)\
\-\ without\\:\\ 0\\.0031437705724346255\ \(0\)\
\-\ imaging\\:\\ 0\\.0031282403507118793\ \(0\)\
\-\ most\\:\\ 0\\.003082554908950119\ \(0\)\
\-\ small\\:\\ 0\\.003075898881845498\ \(0\)\
\-\ well\\:\\ 0\\.003020438989013517\ \(0\)\
\-\ present\\:\\ 0\\.0030156386780182515\ \(0\)\
\-\ left\\:\\ 0\\.0029878289664778588\ \(0\)\
\-\ year\\:\\ 0\\.0029878289664778588\ \(0\)\
\-\ \\'s\\:\\ 0\\.002943822841198508\ \(0\)\
\-\ multiple\\:\\ 0\\.002812196880436358\ \(0\)\
\-\ old\\:\\ 0\\.0027341706151945457\ \(0\)\
\-\ no\\:\\ 0\\.0026888879709493813\ \(0\)\
\-\ seen\\:\\ 0\\.0026384806485432663\ \(0\)\
\-\ that\\:\\ 0\\.0023062198883731615\ \(0\)\
\-\ by\\:\\ 0\\.0022232357863201167\ \(0\)\
\-\ disease\\:\\ 0\\.002182402408149538\ \(0\)\
\-\ of\\:\\ 0\\.0020024090762154265\ \(0\)\
\-\ there\\:\\ 0\\.001987055556976545\ \(0\)\
\-\ \\.\\:\\ 0\\.0019413808803236245\ \(0\)\
\-\ ct\\:\\ 0\\.0018676619584250672\ \(0\)\
\-\ an\\:\\ 0\\.0018463513504448905\ \(0\)\
\-\ history\\:\\ 0\\.0018440852151673179\ \(0\)\
\-\ with\\:\\ 0\\.0018281902514045271\ \(0\)\
\-\ \\:\\:\\ 0\\.0017660543999854141\ \(0\)\
\-\ is\\:\\ 0\\.0017571586824522676\ \(0\)\
\-\ this\\:\\ 0\\.001501776895803333\ \(0\)\
\-\ \\(\\:\\ 0\\.0011286901972560322\ \(0\)\
\-\ \\)\\:\\ 0\\.0011149026439270392\ \(0\)\
